Please login to the form below

Not currently logged in
Email:
Password:

Ovid Therapeutics adds member to scientific advisory board

Dr Jerome Zeldis joins the firm
ovid Therapeutics

New York-based Ovid Therapeutics has appointed Dr Jerome Zeldis to its scientific advisory board.

Ovid is a privately-held biopharmaceutical company focused on developing therapies for rare and orphan diseases of the brain.

Dr Zeldis has been noted for his successful experience in drug development and previously served as Celgene's senior VP of clinical research and medical affairs.

Prior to joining Celgene in 1997, Dr Zeldis was associate director of clinical research at Sandoz Research Institute and director of medical development at Janssen Pharmaceutical Research Institute.

He said: “Ovid is pursuing an ambitious approach of tackling rare neurological diseases with significant unmet needs. With this goal, the company has assembled a world-class leadership and is employing a science-based approach to target new pathways that are involved in these diseases.

“I look forward to working closely with Ovid's team.”

Jeremy Levin, CEO and chairman of Ovid, added: “We are delighted and privileged to welcome Jerry to our scientific advisory board.

“Jerry's advice and insight will be extremely valuable as we enter the clinic.”

12th October 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics